This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
25 Oct 2025

BFS- Ciprofloxacin 10ml (Ciprofloxacin - Solution for injection)

Composition



Ciprofloxacin 200mg/10ml


Dosage Form




Solution for injection



Indication



Ciprofloxacin is indicated for severe infections where conventional antibiotics no longer work to prevent the development of ciprofloxacin-resistant bacteria.

Dosage Administration




The solution for infusion should be administered over an infusion period of 60 minutes. 




The dosage is determined by the indication, the severity and the site of the infection, the susceptibility to ciprofloxacin of the causative organism(s), the renal function of the patient and, in children and adolescents the body weight.




The duration of treatment depends on the severity of the illness and on the clinical and bacteriological course.




After intravenous initiation of treatment, the treatment can be switched to oral treatment with tablet or suspension if clinically indicated at the discretion of the physician. IV treatment should be followed by oral route as soon as possible.
 

Mentioned Companies
Ha Noi CPC1 Pharmaceutical Joint Stock Company
View company profile